5ht5
From Proteopedia
(Difference between revisions)
(New page: '''Unreleased structure''' The entry 5ht5 is ON HOLD Authors: Cody, V. Description: 6-substituted pyrrolo[2,3-d]pyrimidine 6-thieno-(4-methoxyphenyl) [[Category: Unreleased Structures]...) |
|||
(4 intermediate revisions not shown.) | |||
Line 1: | Line 1: | ||
- | '''Unreleased structure''' | ||
- | + | ==6-substituted pyrrolo[2,3-d]pyrimidine 6-thieno-(4-methoxyphenyl)== | |
+ | <StructureSection load='5ht5' size='340' side='right'caption='[[5ht5]], [[Resolution|resolution]] 1.90Å' scene=''> | ||
+ | == Structural highlights == | ||
+ | <table><tr><td colspan='2'>[[5ht5]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5HT5 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5HT5 FirstGlance]. <br> | ||
+ | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.9Å</td></tr> | ||
+ | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=65H:6-[(4-METHOXYPHENYL)SULFANYL]-5,7-DIMETHYL-7H-PYRROLO[2,3-D]PYRIMIDINE-2,4-DIAMINE'>65H</scene>, <scene name='pdbligand=NDP:NADPH+DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE+PHOSPHATE'>NDP</scene></td></tr> | ||
+ | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5ht5 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5ht5 OCA], [https://pdbe.org/5ht5 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5ht5 RCSB], [https://www.ebi.ac.uk/pdbsum/5ht5 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5ht5 ProSAT]</span></td></tr> | ||
+ | </table> | ||
+ | == Disease == | ||
+ | [https://www.uniprot.org/uniprot/DYR_HUMAN DYR_HUMAN] Defects in DHFR are the cause of megaloblastic anemia due to dihydrofolate reductase deficiency (DHFRD) [MIM:[https://omim.org/entry/613839 613839]. DHFRD is an inborn error of metabolism, characterized by megaloblastic anemia and/or pancytopenia, severe cerebral folate deficiency, and cerebral tetrahydrobiopterin deficiency. Clinical features include variable neurologic symptoms, ranging from severe developmental delay and generalized seizures in infancy, to childhood absence epilepsy with learning difficulties, to lack of symptoms.<ref>PMID:21310276</ref> <ref>PMID:21310277</ref> | ||
+ | == Function == | ||
+ | [https://www.uniprot.org/uniprot/DYR_HUMAN DYR_HUMAN] Key enzyme in folate metabolism. Contributes to the de novo mitochondrial thymidylate biosynthesis pathway. Catalyzes an essential reaction for de novo glycine and purine synthesis, and for DNA precursor synthesis. Binds its own mRNA and that of DHFRL1.<ref>PMID:21876188</ref> <ref>PMID:12096917</ref> | ||
- | + | ==See Also== | |
- | + | *[[Dihydrofolate reductase 3D structures|Dihydrofolate reductase 3D structures]] | |
- | + | == References == | |
- | [[Category: | + | <references/> |
- | [[Category: Cody | + | __TOC__ |
+ | </StructureSection> | ||
+ | [[Category: Homo sapiens]] | ||
+ | [[Category: Large Structures]] | ||
+ | [[Category: Cody V]] |
Current revision
6-substituted pyrrolo[2,3-d]pyrimidine 6-thieno-(4-methoxyphenyl)
|